Onbo subcutaneous injection 100mg autoinjector, from Eli Lilly Japan, contains mirikizumab (genetical recombination). This IL-23 inhibitor is used for the treatment of moderate-to-severe active ulcerative colitis and Crohn’s disease in adults. It is supplied as 100mg x 1mL kit with YJ code 2399407G2020.
Onbo subcutaneous injection 100mg autoinjector
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).